Bortezomib- Bortenat 2mg Inj

Information About Bortezomib- Bortenat 2mg Inj

About Bortezomib- Bortenat 2mg Inj

The Medicine Brand Bortenat 2Mg Inj is manufactured by Natco Pharma Limited and mainly contents the generic drug Bortezomib.

Pakaging

Active Ingredients For Bortezomib- Bortenat 2mg Inj

Bortezomib 2 mg

Diseases List For Which Bortezomib- Bortenat 2mg Inj Is Prescribed

This Drug Is Prescribed For Multiple myeloma and mantle cell lymphoma

Other Significations For Bortezomib- Bortenat 2mg Inj

This Medication This medication is a cancer chemotherapy drug used to treat certain types of tumors eg multiple myeloma It blocks certain proteins which helps to slow the growth and spread of the cancer

Precautions To Be Taken Before Bortezomib- Bortenat 2mg Inj

Drug interactions may change how your medications work or increase your risk for serious side effects This document does not contain all possible drug interactions Keep a list of all the products you use including prescriptionnonprescription drugs and herbal products and share it with your doctor and pharmacist Do not start stop or change the dosage of any medicines without your doctors approvalSome products that may interact with this drug include medications to treat high blood pressure oral antidiabetic drugs other drugs that may cause peripheral neuropathy eg amiodarone isoniazid nitrofurantoin certain antivirals such as acyclovir ritonavir zidovudineOther medications can affect the removal of bortezomib from your body which may affect how bortezomib works Examples include azole antifungals such as ketoconazole macrolide antibiotics such as erythromycin rifamycins such as rifabutin St Johns wort drugs used to treat seizures such as carbamazepine phenytoin among others

Major Conditions And Care

Pregnancy And Bortezomib- Bortenat 2mg Inj

Can We Take Bortezomib- Bortenat 2mg Inj During Pregnancy?

Pregnancy Class C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and wellcontrolled studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks

Lactation And Bortezomib- Bortenat 2mg Inj

Can We Use Bortezomib- Bortenat 2mg Inj During Lactation

Lactation Class L5 Studies in breastfeeding mothers have demonstrated that there is significant and documented risk to the infant based on human experience or it is a medication that has a high risk of causing significant damage to an infant The risk of using the drug in breastfeeding women clearly outweighs any possible benefit from breastfeeding The drug is contraindicated in women who are breastfeeding an infant

Side Effects Of Bortezomib- Bortenat 2mg Inj

Nausea stomach upset skin rash acute toxicity

More Danger Effects Fatal Effect Due To Overdose Of Bortezomib- Bortenat 2mg Inj